Lanean...
Tumour-agnostic drugs in paediatric cancers
The recognition that new cancer drugs can be truly tumour-agnostic based on mechanism-of-action is important for paediatric cancers, where access to novel targeted therapies developed for adult indications has sometimes been problematic. The recently approved drug larotrectinib is an excellent case...
Gorde:
| Argitaratua izan da: | Br J Cancer |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Nature Publishing Group UK
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7217925/ https://ncbi.nlm.nih.gov/pubmed/32161367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-020-0770-5 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|